Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Catalent has announced it is investing up to $40 million at its manufacturing facility in Winchester, Kentucky to increase the site’s formulation and controlled-release tablet and capsule manufacturing capabilities and capacity. New technologies...

The latest news from CDMOs, CMOs, and suppliers featuring news from Vetter, Catalent, Cambrex,  Sharp and Biotechpharma.  Chemicals/Chemical API Manufacturing Cambrex Completes Construction for High-Potency API Facility and QC Lab...

Catalent has agreed to acquire Paragon Bioservices, a Baltimore, Maryland-based contract provider of viral vector development and manufacturing services for gene therapies, for $1.2 billion. Paragon has specialized expertise in adeno-associated...

The latest news from CDMOs, CMOS, and other suppliers featuring news from Wilmington PharmaTech, Insilico, ACG Group, Lonza Chemicals/Chemical API Manufacturing Wilmington PharmaTech To Invest $18 Million In New Research and Mfg Facility...

GE has entered into a definitive agreement to sell its BioPharma business to Danaher Corporation, a global science and technology company, headquartered in Washington D.C., for a total consideration of $21.4 billion, including $21 billion in cash...

The latest news from contract development and manufacturing organizations, contract manufacturing organizations, and other suppliers featuring news from Cerbios-Pharma, Olon, Hovione, Thermo Fisher, GE Healthcare Life Sciences, and PCI Pharma...

  A roundup of news from suppliers, contract development and manufacturing organizations (CDMOs), and contract manufacturing organizations (CMOs), featuring developments from Almac, Pii, PCI Pharma Services, MedPharm, and Thousand Oaks...